In prostate cancer, mesenchymal stem cells are recruited from bone marrow contact with prostate cancer cells in the tumor microenvironment and then trans-differentiated into CAF-like cells via TGF-β signaling [28]. The gene discussed is TGFB1; the disease is neoplasm.